Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy

Abstract EN

RNA interference (RNAi) is a gene regulation mechanism initiated by RNA molecules that enables sequence-specific gene silencing by promoting degradation of specific mRNAs.

Molecular therapy using small interfering RNA (siRNA) has shown great therapeutic potential for diseases caused by abnormal gene overexpression or mutation.

The major challenges to application of siRNA therapeutics include the stability and effective delivery of siRNA in vivo.

Important progress in nanotechnology has led to the development of efficient siRNA delivery systems.

In this review, the authors discuss recent advances in nanoparticle-mediated siRNA delivery and the application of siRNA in clinical trials for cancer therapy.

This review will also offer perspectives on future applications of siRNA therapeutics.